Search Orphan Drug Designations and Approvals
-
Generic Name: | Fibrinogen (human) |
---|---|
Date Designated: | 08/23/1995 |
Orphan Designation: | For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Alpha Therapeutic Corporation 5555 Valley Boulevard Los Angeles, California 90032 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-